The treatment from Sarepta Therapeutics was approved Thursday for children ages 4 and 5 with Duchenne muscular dystrophy, a rare muscle-wasting disease that causes early death.
  • anji
    1•2 years ago

    I hope it really works. Muscular dystrophy is such a bag of dicks. Poor kids.